Methicillin-Resistant Staphylococcus AureusMOSARNCT00773864
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
An observational study of Methicillin-Resistant Staphylococcus Aureus and ESBL, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.
Trial summary
Medical staff will be screened for MRSA and ESBL (including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff). PURPOSE: To define the carriage of, and risk factors for carriage of resistant organisms among healthcare employees of carriers of resistant bacteria. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Methicillin-Resistant Staphylococcus Aureus, ESBL
- How many people
- 150 participants
- Where
- 1 siteIsrael
- Study dates
- Oct 2008to Jan 2014
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Healthcare employees) including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff) who work in the rehabilitation center
Who may be able to join
- Health care employees
Who cannot join
- Age 18 years or less
Trial locations and contacts
1 site in 1 country.
Israel1 site
Tasmc
Tel Aviv, 64239
Yaffa lerman, md, 97252-4266910, yaffale@tasmc.health.gov.il
About this study
Official title: Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community- the Role of Healthcare Workers
Medical staff will be screened for MRSA and ESBL (including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff).
PURPOSE:
To define the carriage of, and risk factors for carriage of resistant organisms among healthcare employees of carriers of resistant bacteria.
To define activities of healthcare employees who likely to lead to dissemination of resistant bacteria in rehabilitation centers.
Read the detailed description
Detailed activity:
Medical staff will be screened for MRSA and ESBL (including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff).
Screening will be performed by obtaining nares and perirectal cultures. Nares cultures will be obtained by ward staff or research personnel who are experienced in performing this activity: a moisture swab will be applied gently to the distal part of both nares. Perirectal cultures, will be taken by swab, who will be applied to the perirectal area, either by staff as mentioned above, or will be given to the healthcare workers to perform by himself (with explanation on how to perform it).
- Conditions
- Methicillin-Resistant Staphylococcus Aureus, ESBL
- Keywords
- Healthcare employees who work in the rehabilitation center
What is being measured
The primary outcome is the main question the study is designed to answer.
Healthcare employees) including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff) who work in the rehabilitation center
Measured: 1 YEAR
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Oct 2008 (estimated)
- Study startOct 2008
- Primary completionOct 2009 (estimated)
- Study completionJan 2014 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Methicillin-Resistant Staphylococcus AureusStudies of the same condition, open and under way.
- More trials run by Tel-Aviv Sourasky Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Sponsor type
- Other government
- Investigators
- Yehuda carmeli, MD MPH, Principal investigator, TASMC
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00773864
- Sponsor's protocol ID
- TASMC-08-YC-254-CTIL
- Acronym
- MOSAR
- Status last verified
- Oct 2008
- First submitted
- 6 Oct 2008
- Last updated
- 16 Oct 2008
- Results posted
- No
- Data monitoring committee
- No
Publications
Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis. 2008 May;8(5):289-301. doi: 10.1016/S1473-3099(08)70097-5.
PubMed 18471774Carmeli Y, Venkataraman L, DeGirolami PC, Lichtenberg DA, Karchmer AW, Samore MH. Stool colonization of healthcare workers with selected resistant bacteria. Infect Control Hosp Epidemiol. 1998 Jan;19(1):38-40. doi: 10.1086/647705.
PubMed 9475348
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community- the Role of Healthcare Workers
- ClinicalTrials.gov ID
- NCT00773864
- Acronym / sponsor ID
- MOSAR / TASMC-08-YC-254-CTIL
- Conditions
- Methicillin-Resistant Staphylococcus Aureus, ESBL
- Keywords
- Healthcare employees who work in the rehabilitation center
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Tel-Aviv Sourasky Medical CenterOther government
- Study start
- Oct 2008
- Primary completion
- Oct 2009 (estimated)
- Study completion
- Jan 2014 (estimated)
- First posted
- 16 Oct 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Medical staff will be screened for MRSA and ESBL (including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff).
PURPOSE:
To define the carriage of, and risk factors for carriage of resistant organisms among healthcare employees of carriers of resistant bacteria.
To define activities of healthcare employees who likely to lead to dissemination of resistant bacteria in rehabilitation centers.
Detailed description
Detailed activity:
Medical staff will be screened for MRSA and ESBL (including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff).
Screening will be performed by obtaining nares and perirectal cultures. Nares cultures will be obtained by ward staff or research personnel who are experienced in performing this activity: a moisture swab will be applied gently to the distal part of both nares. Perirectal cultures, will be taken by swab, who will be applied to the perirectal area, either by staff as mentioned above, or will be given to the healthcare workers to perform by himself (with explanation on how to perform it).
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Healthcare employees) including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff) who work in the rehabilitation center
Key inclusion criteria (1 listed)
- Health care employees
Key exclusion criteria (1 listed)
- Age 18 years or less
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Healthcare employees) including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff) who work in the rehabilitation center
Time frame: 1 YEAR
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2008.
- Background: PubMed 18471774Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis. 2008 May;8(5):289-301. doi: 10.1016/S1473-3099(08)70097-5.
- Background: PubMed 9475348Carmeli Y, Venkataraman L, DeGirolami PC, Lichtenberg DA, Karchmer AW, Samore MH. Stool colonization of healthcare workers with selected resistant bacteria. Infect Control Hosp Epidemiol. 1998 Jan;19(1):38-40. doi: 10.1086/647705.
Related trials for Methicillin-Resistant Staphylococcus Aureus
Not yet recruiting
Farm-originated Antimicrobial Resistance Modeling: Exploring Humans-to-Animal Dissemination
Methicillin-Resistant Staphylococcus Aureus Colonization
RecruitingPhase 4
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia
Not yet recruitingObservational study
Gene Expression Analysis of Biofilm Formation and Antimicrobial Resistance in Clinical Methicillin-Resistant Staphylococcus Aureus
Staphylococcal Aureus Infection, Surgical Site Infection (SSI)
Not yet recruitingPhase 2
A Clinical Trial of Resistant Potato Starch for Gut MDRO Decolonization
Clostridium Infections, Methicillin-resistant Staphylococcus Aureus (MRSA)
RecruitingPhase 4
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Methicillin Resistant Staphylococcus Aureus, Osteomyelitis Acute
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yehuda carmeli, MD MPH principal investigator
TASMC
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Methicillin-Resistant Staphylococcus Aureus and ESBL, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Oct 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact yaffa LERMAN, MD (97252-4266910, yaffale@tasmc.health.gov.il), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Healthcare employees) including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff) who work in the rehabilitation center (time frame: 1 YEAR). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00773864, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2008.